Viz.ai, Cercare Medical Partner to Improve Neurovascular Decision-Making

Viz.ai is joining forces with Cercare Medical to provide clinicians with better decision-making abilities for neurovascular cases. The partnership will incorporate Cercare Perfusion, a fully-automated patient-specific perfusion software, into the Viz.ai platform. 
 
“We are thrilled to join forces with another revolutionary technology company like Cercare,” said Steve Sweeny, vice president of business development and strategy at Viz.ai. “This partnership is another example of our continued commitment to work with like-minded companies to enable quick access to important patient data and ultimately improve clinical impact with our Viz platform.”
 
Viz is broadening its imaging features and functionality to best serve institutions that perform magnetic resonance imaging in the patient workflow. The infusion of Cercare Perfusion technology into the Viz.ai platform enhances the company’s flagship AI-powered neurovascular portfolio as well as the platform’s capabilities.  
 
Brain perfusion scans measure blood flow in the brain and are used to provide critically needed information on the extent of tissue damage due, for instance, to acute ischemic stroke.¹ Quickly mapping brain perfusion deficits is pivotal to minimize tissue damage in acute stroke management, and Cercare further enriches the workflow with layers of AI to produce volumetric measures, which directly impact clinical decision-making.²
 
“Viz.ai and Cercare Medical share the commitment to support clinical decision-making to enable the best possible patient care,” Cercare Medical CEO Kim Beuschau Mouridsen said. “We are pleased to enter into this global partnership to increase access to the latest perfusion technology, which is designed to easily integrate into existing workflows to provide healthcare professionals with deep, fast, and reliable patient insights.”
 
Cercare uniquely provides maps illustrating oxygen availability, in addition to blood flow and volume. This allows more detailed assessment of tissue pathology and therefore optimized patient management for a variety of conditions, such as dementia and neoplasia. 
 
Viz.ai uses AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 200 million lives across 1,200-plus hospitals and health systems in the United States and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a particular disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by clinical data, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies. 
 
Founded as a spin-out in 2013 from Aarhus University, Denmark, Cercare Medical delivers the potential of perfusion imaging with a fully-automated and multi-vendor compatible software solution for CT and MRI Perfusion imaging post-processing. Its focus, based on the mechanism of a disease, the apprehension and detection of primary and collateral symptoms of microvascular conditions, allows clinicians to develop a final interpretation for both diagnosis support and patient follow-up. 

References 
¹ Dynamics of cerebral perfusion and oxygenation parameters following endovascular treatment of acute ischemic stroke. BMJ Journals www.jnis.bmj.com/content/14/1/neurintsurg-2020-017163 
² The Role of the Cerebral Capillaries in Acute Ischemic Stroke: The Extended Penumbra Model. Sage Journals www.journals.sagepub.com/doi/10.1038/jcbfm.2013.18